Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
ERI3	79033	broad.mit.edu	37	1	44750539	44750539	+	Missense_Mutation	SNP	C	C	A			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr1:44750539C>A	ENST00000372257.2	-	7	980	c.799G>T	c.(799-801)Gat>Tat	p.D267Y	ERI3_ENST00000495828.1_5'UTR|ERI3_ENST00000372259.5_Missense_Mutation_p.D152Y|ERI3_ENST00000537474.1_Missense_Mutation_p.D90Y	NM_024066.1	NP_076971.1	O43414	ERI3_HUMAN	ERI1 exoribonuclease family member 3	267	Exonuclease.	NA		NA		intracellular	exonuclease activity|metal ion binding|nucleic acid binding			endometrium(2)|large_intestine(2)|lung(7)|ovary(3)|upper_aerodigestive_tract(1)|urinary_tract(1)	16						TTGAAGTAATCCGCCACTGGC	0.527	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													78	77	77	NA		NA	NA	1		NA											NA				44750539		2203	4300	6503	SO:0001583	missense			ENSG00000117419	HGNC:17276	NM_024066	Approved	uc001clt.3	NA	B1AK98|Q5T2T7|Q5T2T9|Q5TG35|Q9BQA0|Q9UEB4	ENST00000372257.2	37	CCDS30696.1	.	.	.	.	.	.	.	.	.	.	C	24.2	4.504266	0.85176	.	.	ENSG00000117419	ENST00000372257;ENST00000372259;ENST00000456170;ENST00000537474;ENST00000433471;ENST00000372253;ENST00000452396	T;T;T;T;T	0.23552	1.9;1.9;1.9;1.9;1.9	5.7	5.7	0.88788	Exonuclease (1);Exonuclease, RNase T/DNA polymerase III (1);Ribonuclease H-like (1);	0.259999	0.32769	N	0.005678	T	0.46190	0.1380	M	0.62723	1.935	0.58432	D	0.999995	D;D	0.59767	0.961;0.986	P;P	0.57057	0.788;0.812	T	0.33497	-0.9866	10	0.59425	D	0.04	.	19.8265	0.96619	0.0:1.0:0.0:0.0	.	189;267	B4DN03;O43414	.;ERI3_HUMAN	Y	267;152;106;90;149;133;149	ENSP00000361331:D267Y;ENSP00000361333:D152Y;ENSP00000390710:D106Y;ENSP00000438360:D90Y;ENSP00000396764:D149Y	ENSP00000361327:D133Y	D	-	1	0	ERI3	44523126	1.000000	0.71417	1.000000	0.80357	0.987000	0.75469	5.407000	0.66363	2.688000	0.91661	0.655000	0.94253	GAT	ERI3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000020243.1	-14.888263	KEEP		-	7.35936	0.040816	4	94	---	---	---	---	1	0.999997	5	967	0	62	6	132	0	62	2	0	0	0	0	0	0	6	132	0	62	2	TP
C1ORF220	0	broad.mit.edu	37	1	178514674	178514674	+	Silent	SNP	G	G	A			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr1:178514674G>A	ENST00000367636.4	+	2	398	c.60G>A	c.(58-60)agG>agA	p.R20R	C1orf220_ENST00000521244.1_3'UTR|C1orf220_ENST00000319387.2_3'UTR						NA		NA		NA							NA						tgagattgagggaggctgaaa	0.498	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													63	56	58	NA		NA	NA	1		NA											NA				178514674		2203	4300	6503	SO:0001819	synonymous_variant								NA		ENST00000367636.4	37																																																																																				C1ORF220-201	NOVEL	basic	protein_coding	NA	protein_coding		53.880354	KEEP		+	54.56791	0.68	17	8	---	---	---	---	1	0.4679803	2	0	0	36	18	8	0	36	2	0	0	0	0	0	0	18	8	0	36	2	TP
CENPF	1063	broad.mit.edu	37	1	214816089	214816089	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr1:214816089G>A	ENST00000366955.3	+	12	4576	c.4408G>A	c.(4408-4410)Gag>Aag	p.E1470K		NM_016343.3	NP_057427.3	P49454	CENPF_HUMAN	centromere protein F, 350/400kDa	1566	2 X 96 AA approximate tandem repeats.	NA		NA	cell differentiation|cell division|cell proliferation|DNA replication|G2 phase of mitotic cell cycle|kinetochore assembly|metaphase plate congression|mitotic cell cycle spindle assembly checkpoint|mitotic prometaphase|muscle organ development|negative regulation of transcription, DNA-dependent|protein transport|regulation of G2/M transition of mitotic cell cycle|regulation of striated muscle tissue development|response to drug	condensed chromosome outer kinetochore|cytosol|midbody|nuclear envelope|nuclear matrix|perinuclear region of cytoplasm|spindle pole	chromatin binding|dynein binding|protein C-terminus binding|protein homodimerization activity|transcription factor binding	p.E1470Q(1)		NS(2)|breast(2)|central_nervous_system(4)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(9)|large_intestine(37)|lung(47)|ovary(7)|prostate(3)|skin(6)|stomach(1)|urinary_tract(1)	126				all cancers(67;0.00836)|OV - Ovarian serous cystadenocarcinoma(81;0.00855)|GBM - Glioblastoma multiforme(131;0.0694)|Epithelial(68;0.0833)		GGGCTTGGAGGAGGGGCTCGT	0.478	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(80;575 1284 11000 14801 43496)					NA		NA		NA		1	Substitution - Missense(1)	lung(1)											70	69	70	NA		NA	NA	1		NA											NA				214816089		2203	4300	6503	SO:0001583	missense			ENSG00000117724	HGNC:1857	NM_016343	Approved	uc001hkm.3	NA	Q13171|Q13246|Q5VVM7	ENST00000366955.3	37	CCDS31023.1	.	.	.	.	.	.	.	.	.	.	G	4.705	0.131048	0.08981	.	.	ENSG00000117724	ENST00000366955	T	0.33216	1.42	4.73	4.73	0.59995	.	0.704021	0.11656	N	0.542353	T	0.18676	0.0448	L	0.29908	0.895	0.09310	N	1	P	0.37864	0.61	B	0.34824	0.19	T	0.06144	-1.0843	10	0.07813	T	0.8	.	8.6306	0.33917	0.0:0.1518:0.6681:0.1801	.	1470	P49454	CENPF_HUMAN	K	1470	ENSP00000355922:E1470K	ENSP00000355922:E1470K	E	+	1	0	CENPF	212882712	0.014000	0.17966	0.059000	0.19551	0.022000	0.10575	0.585000	0.23879	2.334000	0.79466	0.655000	0.94253	GAG	CENPF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000089749.1	204.219946	KEEP		+	204.235693	0.512195	63	60	---	---	---	---	1	0.999852	15	3	0	123	75	74	0	123	2	0	0	0	0	0	0	75	74	0	123	2	TP
EPRS	2058	broad.mit.edu	37	1	220154727	220154727	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr1:220154727T>C	ENST00000366923.3	-	24	3715	c.3446A>G	c.(3445-3447)aAt>aGt	p.N1149S		NM_004446.2	NP_004437.2	P07814	SYEP_HUMAN	glutamyl-prolyl-tRNA synthetase	1149	Prolyl-tRNA synthetase.	NA		NA	glutamyl-tRNA aminoacylation|prolyl-tRNA aminoacylation|protein complex assembly	cytosol|soluble fraction	ATP binding|glutamate-tRNA ligase activity|proline-tRNA ligase activity|protein binding|RNA binding			breast(2)|endometrium(11)|kidney(2)|large_intestine(13)|lung(24)|ovary(1)|prostate(3)|skin(2)|stomach(2)|urinary_tract(3)	63				GBM - Glioblastoma multiforme(131;0.0735)	L-Glutamic Acid(DB00142)|L-Proline(DB00172)	TACCACCACATTGCACCACTG	0.358	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0								T	SER/ASN	0,4406		0,0,2203	157	137	144	NA	3446	6.1	1	1		144	1,8599	1.2+/-3.3	0,1,4299	no	missense	EPRS	NM_004446.2	46	0,1,6502	CC,CT,TT	NA	0.0116,0.0,0.0077	possibly-damaging	1149/1513	220154727	1,13005	2203	4300	6503	SO:0001583	missense			ENSG00000136628	HGNC:3418	NM_004446	Approved	uc001hly.1	NA	A0AVA9|B9EGH3|Q05BP6|Q05DF8|Q5DSM1|Q5H9S5|Q6PD57|Q86X73	ENST00000366923.3	37	CCDS31027.1	.	.	.	.	.	.	.	.	.	.	T	22.6	4.317076	0.81469	0.0	1.16E-4	ENSG00000136628	ENST00000366923	T	0.66638	-0.22	6.07	6.07	0.98685	Aminoacyl-tRNA synthetase, class II (1);Aminoacyl-tRNA synthetase, class II (G/ H/ P/ S), conserved domain (1);	0.000000	0.85682	D	0.000000	T	0.69269	0.3092	N	0.25201	0.72	0.53005	D	0.999969	D	0.55605	0.972	D	0.64687	0.928	T	0.72272	-0.4342	10	0.59425	D	0.04	-39.4617	12.4026	0.55422	0.0:0.0667:0.0:0.9333	.	1149	P07814	SYEP_HUMAN	S	1149	ENSP00000355890:N1149S	ENSP00000355890:N1149S	N	-	2	0	EPRS	218221350	1.000000	0.71417	0.999000	0.59377	0.996000	0.88848	4.950000	0.63603	2.326000	0.78906	0.533000	0.62120	AAT	EPRS-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000091133.2	570.734961	KEEP		-	571.058117	0.467606	166	189	---	---	---	---	1	1	204	128	0	67	209	228	0	67	2	0	0	0	0	0	0	209	228	0	67	2	TP
TGFA	7039	broad.mit.edu	37	2	70742029	70742029	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr2:70742029G>A	ENST00000295400.6	-	2	303	c.56C>T	c.(55-57)gCg>gTg	p.A19V	TGFA_ENST00000418333.2_Missense_Mutation_p.A19V|TGFA_ENST00000444975.1_Missense_Mutation_p.A25V|TGFA_ENST00000460808.1_5'UTR|TGFA_ENST00000445399.1_Missense_Mutation_p.A19V|TGFA_ENST00000450929.1_Missense_Mutation_p.A25V	NM_001099691.2|NM_003236.3	NP_001093161.1|NP_003227.1	P01135	TGFA_HUMAN	transforming growth factor, alpha	19		NA		NA	activation of MAPK activity|cell proliferation|positive regulation of cell division|positive regulation of epidermal growth factor receptor activity|positive regulation of epithelial cell proliferation|positive regulation of mitosis	cell surface|extracellular space|integral to membrane|plasma membrane	epidermal growth factor receptor binding|growth factor activity|MAP kinase kinase activity|signal transducer activity	p.A19V(1)		haematopoietic_and_lymphoid_tissue(1)|lung(2)|prostate(1)	4						GGCCTGGCACGCAGCCAACAC	0.597	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - Missense(1)	lung(1)											74	65	68	NA		NA	NA	2		NA											NA				70742029		2203	4300	6503	SO:0001583	missense			ENSG00000163235	HGNC:11765		Approved	uc002sgs.4	NA	A8K286|Q15577|Q53SK7|Q9BS56|Q9UEI3|Q9UKM1|Q9UKM2	ENST00000295400.6	37	CCDS1905.1	.	.	.	.	.	.	.	.	.	.	G	5.866	0.344039	0.11126	.	.	ENSG00000163235	ENST00000295400;ENST00000445399;ENST00000418333;ENST00000450929;ENST00000444975;ENST00000394241	T;T;T;T;T;T	0.17213	2.55;2.31;2.31;2.3;2.29;2.3	5.14	2.6	0.31112	.	0.377651	0.24940	N	0.034385	T	0.07098	0.0180	N	0.08118	0	0.24501	N	0.994259	B;B;B;B;B;B;B	0.02656	0.0;0.0;0.0;0.0;0.0;0.0;0.0	B;B;B;B;B;B;B	0.01281	0.0;0.0;0.0;0.0;0.0;0.0;0.0	T	0.36553	-0.9743	10	0.20519	T	0.43	.	6.2326	0.20744	0.7672:0.0:0.2328:0.0	.	25;25;19;19;19;19;19	E7EPT6;F8VNR3;P01135-5;Q9UKM3;P01135-3;P01135-2;P01135	.;.;.;.;.;.;TGFA_HUMAN	V	19;19;19;25;25;19	ENSP00000295400:A19V;ENSP00000387493:A19V;ENSP00000404099:A19V;ENSP00000414127:A25V;ENSP00000404131:A25V;ENSP00000377787:A19V	ENSP00000295400:A19V	A	-	2	0	TGFA	70595537	1.000000	0.71417	0.917000	0.36280	0.231000	0.25187	2.007000	0.40883	0.435000	0.26365	-0.345000	0.07892	GCG	TGFA-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000251870.2	84.516642	KEEP		-	84.99205	0.409091	27	39	---	---	---	---	1	0.3879323	3	0	0	40	38	52	0	40	2	0	0	0	0	0	0	38	52	0	40	2	TP
INPP5D	3635	broad.mit.edu	37	2	234106832	234106832	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr2:234106832G>A	ENST00000359570.5	+	27	2749	c.2749G>A	c.(2749-2751)Gtg>Atg	p.V917M	INPP5D_ENST00000450745.1_Missense_Mutation_p.V681M|INPP5D_ENST00000455936.2_Missense_Mutation_p.V681M			Q92835	SHIP1_HUMAN	inositol polyphosphate-5-phosphatase, 145kDa	929		NA		NA	apoptosis|blood coagulation|leukocyte migration|T cell receptor signaling pathway	cytosol	inositol-polyphosphate 5-phosphatase activity|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity|SH3 domain binding			central_nervous_system(1)|ovary(1)	2		Breast(86;0.0013)|Renal(207;0.00339)|all_hematologic(139;0.0116)|all_lung(227;0.0273)|Acute lymphoblastic leukemia(138;0.0328)|Lung NSC(271;0.0843)		Epithelial(121;1.16e-17)|BRCA - Breast invasive adenocarcinoma(100;0.000479)|LUSC - Lung squamous cell carcinoma(224;0.00655)|Lung(119;0.00802)|GBM - Glioblastoma multiforme(43;0.0185)		GCCCCTGCACGTGAAGCAGAC	0.647	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NSCLC(82;1215 1426 16163 20348 41018)					NA		NA		NA		0													30	34	33	NA		NA	NA	2		NA											NA				234106832		1983	4170	6153	SO:0001583	missense			ENSG00000168918	HGNC:6079	NM_001017915	Approved	uc010zmp.2	NA	O00145|Q13544|Q13545|Q6P5A4|Q92656|Q9UE80	ENST00000359570.5	37		.	.	.	.	.	.	.	.	.	.	G	0.845	-0.740630	0.03088	.	.	ENSG00000168918	ENST00000359570;ENST00000450745;ENST00000455936;ENST00000435188;ENST00000415617;ENST00000445964;ENST00000417661	D;D;D;D;D;D	0.96365	-3.95;-3.99;-3.99;-3.99;-3.99;-3.99	4.92	-0.56	0.11789	.	1.172470	0.05996	N	0.646848	D	0.90837	0.7122	.	.	.	0.09310	N	1	B;B	0.18610	0.029;0.017	B;B	0.11329	0.006;0.003	T	0.78961	-0.1997	9	0.35671	T	0.21	.	1.2884	0.02055	0.4189:0.1565:0.2842:0.1404	.	928;929	Q92835-2;Q92835	.;SHIP1_HUMAN	M	917;681;681;550;550;550;51	ENSP00000352575:V917M;ENSP00000407916:V681M;ENSP00000404610:V681M;ENSP00000400151:V550M;ENSP00000397421:V550M;ENSP00000405338:V550M	ENSP00000352575:V917M	V	+	1	0	INPP5D	233771571	0.016000	0.18221	0.000000	0.03702	0.054000	0.15201	-0.056000	0.11787	-0.359000	0.08150	-1.553000	0.00894	GTG	INPP5D-201	KNOWN	basic	protein_coding	NA	protein_coding		37.970783	KEEP		+	39.185066	0.317073	13	28	---	---	---	---	1	0.9993986	8	32	0	69	14	37	0	69	2	0	0	0	0	0	0	14	37	0	69	2	TP
PPP1R7	5510	broad.mit.edu	37	2	242105797	242105797	+	Missense_Mutation	SNP	C	C	G			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr2:242105797C>G	ENST00000234038.6	+	8	1234	c.760C>G	c.(760-762)Ctg>Gtg	p.L254V	PPP1R7_ENST00000485630.1_3'UTR|PPP1R7_ENST00000402734.1_Missense_Mutation_p.L195V|PPP1R7_ENST00000401987.1_Missense_Mutation_p.L211V|PPP1R7_ENST00000272983.8_Missense_Mutation_p.L211V|PPP1R7_ENST00000407025.1_Missense_Mutation_p.L254V|PPP1R7_ENST00000406106.3_Missense_Mutation_p.L254V|PPP1R7_ENST00000404405.3_Missense_Mutation_p.L248V	NM_002712.1	NP_002703.1	Q15435	PP1R7_HUMAN	protein phosphatase 1, regulatory subunit 7	254		NA		NA		cytoplasm|nucleus	protein binding|protein phosphatase type 1 regulator activity			cervix(1)|endometrium(3)|kidney(1)|large_intestine(6)|lung(9)|ovary(3)	23		all_cancers(19;6.1e-33)|all_epithelial(40;1.07e-13)|Breast(86;0.000141)|Renal(207;0.00528)|all_lung(227;0.0446)|Ovarian(221;0.104)|Lung NSC(271;0.115)|Esophageal squamous(248;0.131)|all_hematologic(139;0.182)|Melanoma(123;0.238)		Epithelial(32;6.92e-32)|all cancers(36;5.35e-29)|OV - Ovarian serous cystadenocarcinoma(60;3.4e-14)|Kidney(56;4.23e-09)|KIRC - Kidney renal clear cell carcinoma(57;4.24e-08)|BRCA - Breast invasive adenocarcinoma(100;3.56e-06)|Lung(119;0.000588)|LUSC - Lung squamous cell carcinoma(224;0.0048)|Colorectal(34;0.0137)|COAD - Colon adenocarcinoma(134;0.096)		CCTGGTGAACCTGCGGGAGCT	0.552	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NSCLC(62;446 1299 5417 11238 27640)					NA		NA		NA		0													105	86	93	NA		NA	NA	2		NA											NA				242105797		2203	4300	6503	SO:0001583	missense			ENSG00000115685	HGNC:9295	NM_002712	Approved	uc002wat.1	NA	B4DFD4|Q9UQE5|Q9UQE6|Q9Y6K4	ENST00000234038.6	37	CCDS2546.1	.	.	.	.	.	.	.	.	.	.	C	19.43	3.825385	0.71143	.	.	ENSG00000115685	ENST00000438799;ENST00000402734;ENST00000423280;ENST00000407025;ENST00000272983;ENST00000234038;ENST00000404405;ENST00000406106;ENST00000401987	T;T;T;T;T;T;T;T;T	0.61040	0.14;0.14;0.14;0.14;0.14;0.14;0.14;0.14;0.14	5.38	3.58	0.41010	.	0.000000	0.85682	D	0.000000	T	0.75443	0.3850	M	0.85859	2.78	0.80722	D	1	D;D;D;D;D;D	0.89917	1.0;1.0;1.0;0.998;0.996;1.0	D;D;D;D;D;D	0.97110	0.999;1.0;0.996;0.982;0.99;0.999	T	0.78216	-0.2290	10	0.87932	D	0	-12.1954	9.8166	0.40856	0.0:0.7798:0.0:0.2202	.	238;195;211;254;254;248	C9JD73;C9J177;Q15435-2;Q15435;Q15435-3;B5MBZ8	.;.;.;PP1R7_HUMAN;.;.	V	238;195;195;254;211;254;248;254;211	ENSP00000396376:L238V;ENSP00000385012:L195V;ENSP00000412092:L195V;ENSP00000385657:L254V;ENSP00000272983:L211V;ENSP00000234038:L254V;ENSP00000385498:L248V;ENSP00000385022:L254V;ENSP00000385466:L211V	ENSP00000234038:L254V	L	+	1	2	PPP1R7	241754470	1.000000	0.71417	1.000000	0.80357	0.991000	0.79684	1.516000	0.35856	1.273000	0.44346	-0.136000	0.14681	CTG	PPP1R7-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000257244.4	57.68425	KEEP		+	58.384828	0.377358	20	33	---	---	---	---	1	1	192	198	0	52	26	46	0	52	2	0	0	0	0	0	0	26	46	0	52	2	TP
CAND2	23066	broad.mit.edu	37	3	12856870	12856870	+	Missense_Mutation	SNP	T	T	A			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr3:12856870T>A	ENST00000456430.2	+	8	1278	c.1237T>A	c.(1237-1239)Tgg>Agg	p.W413R	CAND2_ENST00000295989.5_Missense_Mutation_p.W320R	NM_001162499.1	NP_001155971.1	O75155	CAND2_HUMAN	cullin-associated and neddylation-dissociated 2 (putative)	413		NA		NA	positive regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	protein binding			breast(3)|central_nervous_system(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(10)|lung(8)|pancreas(1)|prostate(1)|skin(5)|upper_aerodigestive_tract(1)|urinary_tract(1)	37						CCCGAAGGGATGGCTGGAGGC	0.607	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		GBM(43;676 868 1633 6395 37496)					NA		NA		NA		0													42	50	48	NA		NA	NA	3		NA											NA				12856870		2090	4204	6294	SO:0001583	missense			ENSG00000144712	HGNC:30689	XM_371617	Approved	uc003bxk.2	NA	B9EGM9	ENST00000456430.2	37	CCDS54554.1	.	.	.	.	.	.	.	.	.	.	T	4.473	0.087619	0.08583	.	.	ENSG00000144712	ENST00000295989;ENST00000456430	T;T	0.63255	-0.03;-0.03	4.7	3.46	0.39613	Armadillo-like helical (1);Armadillo-type fold (1);	0.096227	0.46758	D	0.000268	T	0.59432	0.2193	N	0.20401	0.57	0.80722	D	1	B;D	0.64830	0.0;0.994	B;D	0.78314	0.002;0.991	T	0.53479	-0.8433	10	0.16420	T	0.52	-22.8013	8.3986	0.32572	0.1753:0.0:0.0:0.8246	.	413;320	O75155;O75155-2	CAND2_HUMAN;.	R	320;413	ENSP00000295989:W320R;ENSP00000387641:W413R	ENSP00000295989:W320R	W	+	1	0	CAND2	12831870	1.000000	0.71417	0.839000	0.33178	0.304000	0.27724	4.556000	0.60775	1.748000	0.51833	0.459000	0.35465	TGG	CAND2-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000339856.4	37.025737	KEEP		+	37.025737	0.5	11	11	---	---	---	---	1	0.9716502	10	0	0	80	13	14	0	80	2	0	0	0	0	0	0	13	14	0	80	2	TP
LRIG1	26018	broad.mit.edu	37	3	66455660	66455660	+	Silent	SNP	C	C	T			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr3:66455660C>T	ENST00000383703.3	-	9	1725	c.1122G>A	c.(1120-1122)acG>acA	p.T374T	LRIG1_ENST00000496559.2_5'UTR|LRIG1_ENST00000273261.3_Silent_p.T374T			Q96JA1	LRIG1_HUMAN	leucine-rich repeats and immunoglobulin-like domains 1	374		NA		NA		integral to membrane				NS(2)|breast(2)|cervix(1)|endometrium(3)|kidney(2)|large_intestine(7)|lung(12)|ovary(3)|prostate(1)|skin(4)|stomach(4)|urinary_tract(1)	42		Lung NSC(201;0.0101)		BRCA - Breast invasive adenocarcinoma(55;0.00047)		AGGCGCCGCTCGTGTCCTCTA	0.612	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													106	90	96	NA		NA	NA	3		NA											NA				66455660		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000144749	HGNC:17360	NM_015541	Approved	uc003dmx.3	NA	Q6IQ51|Q96CF9|Q9BYB8|Q9UFI4	ENST00000383703.3	37																																																																																				LRIG1-002	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000351931.1	112.887178	KEEP		-	113.471377	0.611111	33	21	---	---	---	---	1	1	85	5	0	69	44	30	0	69	2	0	0	0	0	0	0	44	30	0	69	2	TP
OSMR	9180	broad.mit.edu	37	5	38933422	38933422	+	Missense_Mutation	SNP	C	C	A			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr5:38933422C>A	ENST00000274276.3	+	18	3218	c.2816C>A	c.(2815-2817)gCa>gAa	p.A939E		NM_003999.2	NP_003990.1	Q99650	OSMR_HUMAN	oncostatin M receptor	939		NA		NA	cell proliferation|positive regulation of cell proliferation	oncostatin-M receptor complex	growth factor binding|oncostatin-M receptor activity			NS(1)|breast(3)|central_nervous_system(2)|endometrium(1)|kidney(1)|large_intestine(8)|lung(20)|ovary(2)|pancreas(2)|prostate(1)|skin(3)|upper_aerodigestive_tract(2)	46	all_lung(31;0.000365)					CCAGTAGAGGCACCACACTGT	0.493	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													114	118	117	NA		NA	NA	5		NA											NA				38933422		2203	4300	6503	SO:0001583	missense			ENSG00000145623	HGNC:8507	NM_003999	Approved	uc003jln.2	NA	Q6P4E8|Q96QJ6	ENST00000274276.3	37	CCDS3928.1	.	.	.	.	.	.	.	.	.	.	C	5.662	0.306753	0.10733	.	.	ENSG00000145623	ENST00000274276	T	0.41065	1.01	5.06	1.27	0.21489	.	0.706611	0.12910	N	0.429076	T	0.22205	0.0535	N	0.14661	0.345	0.09310	N	1	B	0.17038	0.02	B	0.14023	0.01	T	0.17018	-1.0383	10	0.51188	T	0.08	.	3.9092	0.09196	0.1663:0.5645:0.0:0.2692	.	939	Q99650	OSMR_HUMAN	E	939	ENSP00000274276:A939E	ENSP00000274276:A939E	A	+	2	0	OSMR	38969179	0.000000	0.05858	0.000000	0.03702	0.023000	0.10783	0.549000	0.23329	0.036000	0.15547	0.655000	0.94253	GCA	OSMR-001	KNOWN	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000207609.2	-186.002689	KEEP		+	71.1287	0.034039	37	1050	---	---	---	---	1	0.9721725	4	160	0	194	44	1262	0	194	2	0	0	0	0	0	0	44	1262	0	194	2	TP
MED7	9443	broad.mit.edu	37	5	156566183	156566183	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr5:156566183A>G	ENST00000286317.5	-	2	641	c.260T>C	c.(259-261)aTt>aCt	p.I87T	MED7_ENST00000420343.1_Missense_Mutation_p.I87T	NM_004270.4	NP_004261.1	O43513	MED7_HUMAN	mediator complex subunit 7	87		NA		NA	regulation of transcription from RNA polymerase II promoter|transcription initiation from RNA polymerase II promoter	mediator complex|transcription factor complex	protein binding|transcription coactivator activity			kidney(1)|large_intestine(1)|lung(3)|urinary_tract(2)	7	Renal(175;0.00212)	Medulloblastoma(196;0.0354)|all_neural(177;0.0999)	Kidney(164;0.000171)|KIRC - Kidney renal clear cell carcinoma(164;0.000785)			CAAGAAATTAATAAGGATAGA	0.378	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													53	58	56	NA		NA	NA	5		NA											NA				156566183		2201	4298	6499	SO:0001583	missense			ENSG00000155868	HGNC:2378	NM_004270	Approved	uc003lwm.4	NA		ENST00000286317.5	37	CCDS4334.1	.	.	.	.	.	.	.	.	.	.	A	14.23	2.473215	0.43942	.	.	ENSG00000155868	ENST00000286317;ENST00000420343;ENST00000524289	.	.	.	5.91	4.74	0.60224	.	0.112881	0.64402	D	0.000014	T	0.43612	0.1255	N	0.22421	0.69	0.41796	D	0.989898	B	0.02656	0.0	B	0.10450	0.005	T	0.27773	-1.0064	9	0.44086	T	0.13	-38.6238	11.9911	0.53176	0.9327:0.0:0.0673:0.0	.	87	O43513	MED7_HUMAN	T	87	.	ENSP00000286317:I87T	I	-	2	0	MED7	156498761	1.000000	0.71417	1.000000	0.80357	0.990000	0.78478	7.253000	0.78320	1.056000	0.40484	0.533000	0.62120	ATT	MED7-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000252567.2	96.33231	KEEP		-	97.154391	0.38961	30	47	---	---	---	---	1	0.9999984	25	19	0	151	33	56	0	151	2	0	0	0	0	0	0	33	56	0	151	2	TP
HSP90AB1	3326	broad.mit.edu	37	6	44217828	44217828	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr6:44217828G>C	ENST00000371554.1	+	5	799	c.585G>C	c.(583-585)gaG>gaC	p.E195D	HSP90AB1_ENST00000353801.3_Missense_Mutation_p.E195D|HSP90AB1_ENST00000371646.5_Missense_Mutation_p.E195D			P08238	HS90B_HUMAN	heat shock protein 90kDa alpha (cytosolic), class B member 1	195		NA		NA	axon guidance|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of nitric oxide biosynthetic process|protein folding|regulation of interferon-gamma-mediated signaling pathway|regulation of type I interferon-mediated signaling pathway|response to unfolded protein	cytosol|melanosome	ATP binding|nitric-oxide synthase regulator activity|TPR domain binding|unfolded protein binding			NS(1)|breast(1)|endometrium(6)|kidney(2)|large_intestine(5)|lung(12)|prostate(2)|skin(2)|urinary_tract(2)	33	all_cancers(18;1.7e-05)|all_lung(25;0.00747)|Hepatocellular(11;0.00908)|Ovarian(13;0.0273)		Colorectal(64;0.00337)|COAD - Colon adenocarcinoma(64;0.00536)			ACCTAGAAGAGAGGCGGGTCA	0.428	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													98	101	100	NA		NA	NA	6		NA											NA				44217828		2203	4300	6503	SO:0001583	missense			ENSG00000096384	HGNC:5258	NM_007355	Approved	uc031sor.1	NA	B2R5P0|Q5T9W7|Q9NQW0|Q9NTK6	ENST00000371554.1	37	CCDS4909.1	.	.	.	.	.	.	.	.	.	.	G	14.25	2.480261	0.44044	.	.	ENSG00000096384	ENST00000441736;ENST00000371646;ENST00000353801;ENST00000371554	T;T;T	0.11821	2.74;2.74;2.74	4.49	0.561	0.17285	Heat shock protein Hsp90, N-terminal (1);ATPase-like, ATP-binding domain (2);	0.074396	0.52532	U	0.000072	T	0.11024	0.0269	M	0.89658	3.05	0.80722	D	1	B;B;B	0.06786	0.001;0.0;0.0	B;B;B	0.21151	0.033;0.001;0.002	T	0.04440	-1.0951	10	0.66056	D	0.02	-24.9371	9.6222	0.39727	0.3686:0.0:0.6314:0.0	.	157;185;195	B4DMA2;B4DGL0;P08238	.;.;HS90B_HUMAN	D	147;195;195;195	ENSP00000360709:E195D;ENSP00000325875:E195D;ENSP00000360609:E195D	ENSP00000325875:E195D	E	+	3	2	HSP90AB1	44325806	1.000000	0.71417	0.990000	0.47175	0.891000	0.51852	0.651000	0.24873	0.041000	0.15688	-0.252000	0.11476	GAG	HSP90AB1-005	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000040730.1	97.125948	KEEP		+	97.125948	0.5	27	27	---	---	---	---	1	1	519	474	0	216	45	68	0	216	2	0	0	0	0	0	0	45	68	0	216	2	TP
GSTA4	2941	broad.mit.edu	37	6	52850376	52850376	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr6:52850376G>A	ENST00000370959.1	-	4	262	c.145C>T	c.(145-147)Cac>Tac	p.H49Y	GSTA4_ENST00000370960.1_Intron|GSTA4_ENST00000541324.1_5'UTR|GSTA4_ENST00000486559.1_5'UTR			O15217	GSTA4_HUMAN	glutathione S-transferase alpha 4	49	GST N-terminal.	NA		NA	glutathione metabolic process|xenobiotic metabolic process	cytosol	glutathione transferase activity|protein homodimerization activity			endometrium(1)|lung(3)|skin(2)|urinary_tract(1)	7	Lung NSC(77;0.103)				Glutathione(DB00143)	AACAGCAGGTGGTTACCTGAG	0.458	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													132	121	124	NA		NA	NA	6		NA											NA				52850376		2203	4300	6503	SO:0001583	missense			ENSG00000170899	HGNC:4629	NM_001512	Approved	uc003pbf.3	NA	B2RD15|Q5T7Q8|Q9BX18|Q9H414	ENST00000370959.1	37	CCDS4948.1	.	.	.	.	.	.	.	.	.	.	G	3.847	-0.032706	0.07543	.	.	ENSG00000170899	ENST00000370963;ENST00000370959	T;T	0.06528	3.29;3.29	5.36	3.47	0.39725	Glutathione S-transferase, N-terminal (2);Thioredoxin-like fold (2);	0.381288	0.29692	N	0.011459	T	0.01061	0.0035	N	0.25647	0.755	0.80722	D	1	B	0.12630	0.006	B	0.06405	0.002	T	0.47649	-0.9101	10	0.02654	T	1	-8.6722	3.3622	0.07190	0.1725:0.0:0.585:0.2426	.	49	O15217	GSTA4_HUMAN	Y	49	ENSP00000360002:H49Y;ENSP00000359998:H49Y	ENSP00000359998:H49Y	H	-	1	0	GSTA4	52958335	0.384000	0.25164	1.000000	0.80357	0.971000	0.66376	0.249000	0.18216	2.658000	0.90341	0.655000	0.94253	CAC	GSTA4-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000040946.1	220.848805	KEEP		-	221.508693	0.43125	69	91	---	---	---	---	1	1	118	122	0	169	89	124	0	169	2	0	0	0	0	0	0	89	124	0	169	2	TP
PHF3	23469	broad.mit.edu	37	6	64416078	64416078	+	Missense_Mutation	SNP	A	A	T			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr6:64416078A>T	ENST00000262043.3	+	12	3867	c.3527A>T	c.(3526-3528)cAg>cTg	p.Q1176L	PHF3_ENST00000393387.1_Missense_Mutation_p.Q1176L			Q92576	PHF3_HUMAN	PHD finger protein 3	1176		NA		NA	multicellular organismal development|transcription, DNA-dependent	nucleus	zinc ion binding			breast(7)|cervix(2)|endometrium(8)|kidney(7)|large_intestine(18)|lung(21)|ovary(3)|prostate(1)|skin(2)|upper_aerodigestive_tract(6)	75	all_cancers(3;0.0241)|all_epithelial(2;0.00306)|Lung NSC(77;0.121)		LUSC - Lung squamous cell carcinoma(74;0.0644)|Lung(124;0.148)			GAGGAGAAACAGGAGTCTCCA	0.378	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		GBM(135;136 1820 29512 34071 46235)					NA		NA		NA		0													83	78	79	NA		NA	NA	6		NA											NA				64416078		2203	4300	6503	SO:0001583	missense			ENSG00000118482	HGNC:8921		Approved	uc003pep.1	NA	A3KFI8|Q14CR5|Q5CZI1|Q5T1T6|Q9NQ16|Q9UI45	ENST00000262043.3	37	CCDS4966.1	.	.	.	.	.	.	.	.	.	.	A	13.96	2.393774	0.42410	.	.	ENSG00000118482	ENST00000506783;ENST00000515594;ENST00000262043;ENST00000393387	T;T;T;T	0.48522	2.09;0.81;2.1;2.1	5.79	5.79	0.91817	.	0.000000	0.34676	N	0.003766	T	0.56746	0.2006	L	0.54323	1.7	0.58432	D	0.999991	D	0.76494	0.999	D	0.78314	0.991	T	0.58769	-0.7578	10	0.51188	T	0.08	-12.7372	16.1376	0.81497	1.0:0.0:0.0:0.0	.	1176	Q92576	PHF3_HUMAN	L	990;445;1176;1176	ENSP00000424694:Q990L;ENSP00000425338:Q445L;ENSP00000262043:Q1176L;ENSP00000377048:Q1176L	ENSP00000262043:Q1176L	Q	+	2	0	PHF3	64474037	1.000000	0.71417	0.999000	0.59377	0.894000	0.52154	4.928000	0.63447	2.212000	0.71576	0.533000	0.62120	CAG	PHF3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000041086.2	61.846344	KEEP		+	64.495536	0.295775	21	50	---	---	---	---	1	0.9936986	19	7	0	88	23	63	0	88	2	0	0	0	0	0	0	23	63	0	88	2	TP
EZR	7430	broad.mit.edu	37	6	159210403	159210403	+	Splice_Site	SNP	T	T	C			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr6:159210403T>C	ENST00000367075.3	-	3	181	c.12_splice	c.e3-1	p.I5_splice	EZR_ENST00000476189.1_5'UTR|EZR_ENST00000392177.4_Splice_Site_p.I5_splice|EZR_ENST00000337147.7_Splice_Site_p.I5_splice	NM_001111077.1	NP_001104547.1	P15311	EZRI_HUMAN	ezrin	5	FERM.	NA		NA	actin filament bundle assembly|axon guidance|cytoskeletal anchoring at plasma membrane|leukocyte cell-cell adhesion|membrane to membrane docking|regulation of cell shape	actin filament|apical plasma membrane|basolateral plasma membrane|cortical cytoskeleton|cytosol|extrinsic to membrane|filopodium|microvillus membrane|nucleolus|ruffle membrane	actin filament binding|cell adhesion molecule binding		EZR/ROS1(4)	breast(1)|cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(4)|large_intestine(2)|lung(1)|ovary(1)|prostate(2)	15		Breast(66;0.000776)|Ovarian(120;0.0303)		OV - Ovarian serous cystadenocarcinoma(65;2.16e-17)|BRCA - Breast invasive adenocarcinoma(81;6.58e-06)		CGGACATTGATCTGAAAAACA	0.428	NA	NA	T	ROS1	NSCLC		NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		6	6q25.3	7430	ezrin	NA	E	0													102	92	96	NA		NA	NA	6		NA											NA				159210403		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000092820	HGNC:12691	NM_003379	Approved	uc003qrt.4	NA	E1P5A8|P23714|Q4VX75|Q96CU8|Q9NSJ4	ENST00000367075.3	37	CCDS5258.1	.	.	.	.	.	.	.	.	.	.	T	10.83	1.460666	0.26248	.	.	ENSG00000092820	ENST00000337147;ENST00000367075;ENST00000392177	T;T;T	0.75938	-0.98;-0.98;-0.98	4.67	4.67	0.58626	Band 4.1 domain (1);FERM domain (1);	0.218041	0.47455	D	0.000231	T	0.42245	0.1194	N	0.25426	0.745	0.54753	D	0.999981	B;B	0.02656	0.0;0.0	B;B	0.10450	0.005;0.001	T	0.43393	-0.9394	10	0.27785	T	0.31	.	7.3962	0.26938	0.0:0.1644:0.0:0.8356	.	5;5	E7EQR4;P15311	.;EZRI_HUMAN	V	5	ENSP00000338934:I5V;ENSP00000356042:I5V;ENSP00000376016:I5V	ENSP00000338934:I5V	I	-	1	0	EZR	159130391	1.000000	0.71417	1.000000	0.80357	0.988000	0.76386	1.039000	0.30266	2.074000	0.62210	0.454000	0.30748	ATC	EZR-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000042878.1	84.266012	KEEP	Missense_Mutation	-	88.146532	0.28866	28	69	---	---	---	---	1	1	249	256	0	85	32	76	0	85	2	0	0	0	0	0	0	32	76	0	85	2	TP
MLLT4	4301	broad.mit.edu	37	6	168343837	168343837	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr6:168343837A>G	ENST00000366806.2	+	24	3249	c.3107A>G	c.(3106-3108)tAt>tGt	p.Y1036C	MLLT4_ENST00000507679.1_3'UTR|MLLT4_ENST00000351017.4_Missense_Mutation_p.Y1043C|MLLT4_ENST00000344191.4_Missense_Mutation_p.Y1036C|MLLT4_ENST00000447894.2_Missense_Mutation_p.Y1036C|MLLT4_ENST00000392112.1_Missense_Mutation_p.Y1020C|MLLT4_ENST00000392108.3_Missense_Mutation_p.Y1036C|MLLT4_ENST00000400822.3_Missense_Mutation_p.Y1035C			P55196	AFAD_HUMAN	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4	1036	PDZ.	NA		NA	adherens junction organization|cell adhesion|cell junction assembly|cell-cell signaling|signal transduction	adherens junction|cell-cell junction|cytosol|nucleus	protein C-terminus binding			breast(4)|central_nervous_system(1)|cervix(1)|endometrium(6)|kidney(13)|large_intestine(10)|lung(19)|ovary(2)|pancreas(1)|prostate(2)|skin(1)|stomach(2)|upper_aerodigestive_tract(2)|urinary_tract(1)	65		Breast(66;1.07e-05)|Ovarian(120;0.024)		Epithelial(4;2.38e-32)|OV - Ovarian serous cystadenocarcinoma(33;9.99e-23)|BRCA - Breast invasive adenocarcinoma(4;1.2e-11)|GBM - Glioblastoma multiforme(31;0.00117)		CTAGGAATCTATGTGAAGTCG	0.373	NA	NA	T	MLL	AL		NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		6	6q27	4301	"""myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 (AF6)"""	NA	L	0													178	161	167	NA		NA	NA	6		NA											NA				168343837		2203	4300	6503	SO:0001583	missense			ENSG00000130396	HGNC:7137	NM_005936	Approved	uc021zij.1	NA	O75087|O75088|O75089|Q59FP0|Q5TIG6|Q5TIG7|Q9NSN7|Q9NU92	ENST00000366806.2	37		.	.	.	.	.	.	.	.	.	.	A	22.5	4.300305	0.81136	.	.	ENSG00000130396	ENST00000344191;ENST00000351017;ENST00000392108;ENST00000366806;ENST00000392112;ENST00000341575;ENST00000400822;ENST00000447894	T;T;T;T;T;T;T	0.30448	1.53;1.53;1.53;1.53;1.53;1.53;1.53	5.18	5.18	0.71444	PDZ/DHR/GLGF (4);	0.000000	0.64402	D	0.000001	T	0.58148	0.2102	M	0.92784	3.345	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;0.999;1.0;0.999	T	0.71104	-0.4689	10	0.87932	D	0	-8.0093	15.0548	0.71904	1.0:0.0:0.0:0.0	.	1036;1035;1036;1020	P55196;P55196-5;P55196-6;P55196-2	AFAD_HUMAN;.;.;.	C	1036;1043;1036;1036;1020;1036;1035;1036	ENSP00000341118:Y1036C;ENSP00000252692:Y1043C;ENSP00000375956:Y1036C;ENSP00000355771:Y1036C;ENSP00000375960:Y1020C;ENSP00000383623:Y1035C;ENSP00000404595:Y1036C	ENSP00000345834:Y1036C	Y	+	2	0	MLLT4	168086686	1.000000	0.71417	0.983000	0.44433	0.978000	0.69477	8.558000	0.90704	1.954000	0.56735	0.528000	0.53228	TAT	MLLT4-201	KNOWN	basic	protein_coding	NA	protein_coding		145.823844	KEEP		+	154.342045	0.269663	48	130	---	---	---	---	1	0.9956756	13	13	0	89	63	173	0	89	2	0	0	0	0	0	0	63	173	0	89	2	TP
FAM120B	84498	broad.mit.edu	37	6	170627725	170627725	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr6:170627725G>A	ENST00000476287.1	+	2	1355	c.1247G>A	c.(1246-1248)tGt>tAt	p.C416Y	FAM120B_ENST00000537664.1_Missense_Mutation_p.C439Y|FAM120B_ENST00000252510.9_Intron|FAM120B_ENST00000540480.1_Missense_Mutation_p.C428Y	NM_032448.1	NP_115824.1	Q96EK7	F120B_HUMAN	family with sequence similarity 120B	416		NA		NA	cell differentiation|regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	protein binding			endometrium(8)|haematopoietic_and_lymphoid_tissue(2)|kidney(2)|large_intestine(11)|liver(1)|lung(15)|ovary(1)|prostate(2)|skin(2)	44		Breast(66;0.000338)|Esophageal squamous(34;0.241)		OV - Ovarian serous cystadenocarcinoma(33;3.94e-22)|BRCA - Breast invasive adenocarcinoma(81;6.47e-06)|GBM - Glioblastoma multiforme(31;0.0899)		GTTCCCATGTGTACAGGCCCT	0.522	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													191	202	198	NA		NA	NA	6		NA											NA				170627725		2203	4300	6503	SO:0001583	missense			ENSG00000112584	HGNC:21109	NM_032448	Approved	uc003qxp.3	NA	Q86V68|Q96JI9	ENST00000476287.1	37	CCDS5314.1	.	.	.	.	.	.	.	.	.	.	G	0.894	-0.724414	0.03158	.	.	ENSG00000112584	ENST00000540480;ENST00000537664;ENST00000476287	T;T;T	0.08546	3.08;3.08;3.09	3.25	0.421	0.16451	.	0.786834	0.11493	N	0.558485	T	0.02807	0.0084	M	0.66939	2.045	0.09310	N	0.999999	B;B	0.09022	0.002;0.002	B;B	0.04013	0.001;0.001	T	0.40813	-0.9543	10	0.46703	T	0.11	0.4181	3.0884	0.06285	0.334:0.0:0.4768:0.1892	.	416;416	Q96EK7;F2Z2E1	F120B_HUMAN;.	Y	428;439;416	ENSP00000444125:C428Y;ENSP00000440125:C439Y;ENSP00000417970:C416Y	ENSP00000436640:C416Y	C	+	2	0	FAM120B	170469650	0.004000	0.15560	0.000000	0.03702	0.007000	0.05969	0.715000	0.25822	0.053000	0.16036	-0.119000	0.15052	TGT	FAM120B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000043259.1	-67.275921	KEEP		+	8.447173	0.017361	5	283	---	---	---	---	1	0.9005052	3	73	0	569	19	350	0	569	2	0	0	0	0	0	0	19	350	0	569	2	TP
ZNF79	7633	broad.mit.edu	37	9	130206963	130206963	+	Silent	SNP	C	C	T			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr9:130206963C>T	ENST00000342483.5	+	5	1390	c.984C>T	c.(982-984)acC>acT	p.T328T	ZNF79_ENST00000543471.1_Silent_p.T304T|RPL12_ENST00000497322.1_5'Flank	NM_007135.2	NP_009066.2	Q15937	ZNF79_HUMAN	zinc finger protein 79	328		NA		NA	regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(1)|central_nervous_system(1)|endometrium(2)|kidney(5)|large_intestine(1)|lung(13)|ovary(2)|prostate(1)|stomach(2)	28						GGACTCACACCGGGGAGAAGC	0.557	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													109	100	103	NA		NA	NA	9		NA											NA				130206963		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000196152	HGNC:13153	NM_007135	Approved	uc004bqw.4	NA	Q5VVW1|Q96NV1	ENST00000342483.5	37	CCDS6871.1																																																																																			ZNF79-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000054188.1	-78.951053	KEEP		+	7.630958	0.015385	5	320	---	---	---	---	1	0.1509589	5	30	0	171	7	402	0	171	2	0	0	0	0	0	0	7	402	0	171	2	TP
ZNF79	7633	broad.mit.edu	37	9	130206972	130206972	+	Silent	SNP	G	G	A			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr9:130206972G>A	ENST00000342483.5	+	5	1399	c.993G>A	c.(991-993)aaG>aaA	p.K331K	ZNF79_ENST00000543471.1_Silent_p.K307K|RPL12_ENST00000497322.1_5'Flank	NM_007135.2	NP_009066.2	Q15937	ZNF79_HUMAN	zinc finger protein 79	331		NA		NA	regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(1)|central_nervous_system(1)|endometrium(2)|kidney(5)|large_intestine(1)|lung(13)|ovary(2)|prostate(1)|stomach(2)	28						CCGGGGAGAAGCCCTACAAGT	0.572	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													109	100	103	NA		NA	NA	9		NA											NA				130206972		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000196152	HGNC:13153	NM_007135	Approved	uc004bqw.4	NA	Q5VVW1|Q96NV1	ENST00000342483.5	37	CCDS6871.1																																																																																			ZNF79-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000054188.1	-64.022656	KEEP		+	15.957027	0.027692	9	316	---	---	---	---	1	0.321928	4	31	0	161	12	378	0	161	2	0	0	0	0	0	0	12	378	0	161	2	TP
ARMC4	55130	broad.mit.edu	37	10	28229643	28229643	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr10:28229643G>T	ENST00000305242.5	-	13	1927	c.1835C>A	c.(1834-1836)gCa>gAa	p.A612E	ARMC4_ENST00000545014.1_Missense_Mutation_p.A137E|ARMC4_ENST00000537576.1_Missense_Mutation_p.A304E	NM_018076.2	NP_060546.2	Q5T2S8	ARMC4_HUMAN	armadillo repeat containing 4	612		NA		NA			binding			NS(2)|breast(2)|central_nervous_system(1)|cervix(1)|endometrium(7)|kidney(6)|large_intestine(17)|liver(1)|lung(17)|ovary(5)|prostate(3)|skin(8)|stomach(2)|urinary_tract(3)	75						CAGGGCCAGTGCCCCACAGCG	0.517	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													87	83	84	NA		NA	NA	10		NA											NA				28229643		2203	4300	6503	SO:0001583	missense			ENSG00000169126	HGNC:25583	NM_018076	Approved	uc001itz.3	NA	Q9H0C0	ENST00000305242.5	37	CCDS7157.1	.	.	.	.	.	.	.	.	.	.	G	20.7	4.029292	0.75504	.	.	ENSG00000169126	ENST00000537576;ENST00000305242;ENST00000545014	T;T;T	0.68624	-0.34;-0.34;-0.34	4.83	4.83	0.62350	Armadillo-like helical (1);Armadillo-type fold (2);	0.096930	0.64402	D	0.000001	D	0.84800	0.5552	M	0.88570	2.965	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.81914	0.995;0.995	D	0.88051	0.2787	10	0.72032	D	0.01	-8.973	18.2808	0.90097	0.0:0.0:1.0:0.0	.	137;612	B7Z7I1;Q5T2S8	.;ARMC4_HUMAN	E	304;612;137	ENSP00000443208:A304E;ENSP00000306410:A612E;ENSP00000441076:A137E	ENSP00000306410:A612E	A	-	2	0	ARMC4	28269649	1.000000	0.71417	0.940000	0.37924	0.261000	0.26267	9.436000	0.97532	2.384000	0.81235	0.655000	0.94253	GCA	ARMC4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000047339.1	151.835117	KEEP		-	152.173147	0.565217	52	40	---	---	---	---	1	0.605496	3	0	0	111	63	46	0	111	2	0	0	0	0	0	0	63	46	0	111	2	TP
LINC00842	0	broad.mit.edu	37	10	47133709	47133709	+	lincRNA	SNP	G	G	C			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr10:47133709G>C	ENST00000422732.2	-	0	435					NR_033957.1					NA		NA		NA							NA						GAACCACTTCGACCTCTTTGG	0.468	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA										NA		ENST00000422732.2	37																																																																																				LINC00842-002	KNOWN	basic	lincRNA	NA	lincRNA	OTTHUMT00000047838.2	-22.207042	KEEP		-	8.868439	0.031008	4	125	---	---	---	---	1	0.2094106	3	43	1	137	4	145	1	137	3	0	0	0	0	0	0	4	145	1	137	2	TP
MMP13	4322	broad.mit.edu	37	11	102822797	102822797	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr11:102822797C>T	ENST00000260302.3	-	5	771	c.743G>A	c.(742-744)gGc>gAc	p.G248D	MMP13_ENST00000340273.4_Missense_Mutation_p.G248D	NM_002427.3	NP_002418.1	P45452	MMP13_HUMAN	matrix metallopeptidase 13 (collagenase 3)	248		NA		NA	collagen catabolic process|proteolysis	extracellular space	metalloendopeptidase activity|zinc ion binding	p.G248D(1)		NS(1)|breast(1)|endometrium(1)|kidney(1)|large_intestine(4)|lung(15)|ovary(2)|skin(1)|stomach(1)	27		all_hematologic(158;0.00092)|Acute lymphoblastic leukemia(157;0.000967)		BRCA - Breast invasive adenocarcinoma(274;0.0144)		GTGGCTTTTGCCGGTGTAGGT	0.448	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - Missense(1)	kidney(1)											248	239	242	NA		NA	NA	11		NA											NA				102822797		2202	4299	6501	SO:0001583	missense			ENSG00000137745	HGNC:7159	NM_002427	Approved	uc001phl.3	NA		ENST00000260302.3	37	CCDS8324.1	.	.	.	.	.	.	.	.	.	.	C	5.496	0.276438	0.10403	.	.	ENSG00000137745	ENST00000260302;ENST00000546012;ENST00000340273	T;T	0.46819	0.86;0.86	5.59	4.68	0.58851	Peptidase M10, metallopeptidase (1);Peptidase, metallopeptidase (1);Metallopeptidase, catalytic domain (1);	0.207964	0.52532	N	0.000079	T	0.16557	0.0398	N	0.01417	-0.88	0.44635	D	0.99761	B	0.02656	0.0	B	0.08055	0.003	T	0.20706	-1.0267	10	0.02654	T	1	.	10.717	0.46019	0.0:0.8549:0.0:0.1451	.	248	P45452	MMP13_HUMAN	D	248	ENSP00000260302:G248D;ENSP00000339672:G248D	ENSP00000260302:G248D	G	-	2	0	MMP13	102328007	0.817000	0.29147	1.000000	0.80357	0.983000	0.72400	1.516000	0.35856	1.479000	0.48272	0.655000	0.94253	GGC	MMP13-001	NOVEL	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000386648.1	-208.186727	KEEP		-	10.407118	0.008929	7	777	---	---	---	---	0	0	0	0	0	367	11	982	0	367	2	1	0.9435928	2	439	0	655	11	982	0	367	2	TP
PNP	4860	broad.mit.edu	37	14	20942702	20942702	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr14:20942702T>C	ENST00000361505.5	+	3	399	c.253T>C	c.(253-255)Ttc>Ctc	p.F85L	RP11-203M5.8_ENST00000554678.1_lincRNA	NM_000270.3	NP_000261.2	P00491	PNPH_HUMAN	purine nucleoside phosphorylase	85		NA		NA	immune response|inosine catabolic process|interleukin-2 secretion|NAD biosynthesis via nicotinamide riboside salvage pathway|nicotinamide riboside catabolic process|positive regulation of alpha-beta T cell differentiation|positive regulation of T cell proliferation|purine base metabolic process|purine nucleotide catabolic process|purine-containing compound salvage|response to drug|urate biosynthetic process	cytoskeleton|cytosol	drug binding|nucleoside binding|phosphate binding|purine base binding|purine-nucleoside phosphorylase activity			cervix(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(1)|lung(1)|ovary(2)|stomach(2)	10					Aciclovir(DB00787)|Cladribine(DB00242)|Mercaptopurine(DB01033)	GCAGGGCAGGTTCCACATGTA	0.502	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													130	111	117	NA		NA	NA	14		NA											NA				20942702		2203	4300	6503	SO:0001583	missense			ENSG00000198805	HGNC:7892	NM_000270.2	Approved	uc001vxo.4	NA	B2R8S5|D3DS00|Q15160|Q5PZ03	ENST00000361505.5	37	CCDS9552.1	.	.	.	.	.	.	.	.	.	.	T	31	5.093294	0.94149	.	.	ENSG00000198805	ENST00000553418;ENST00000361505;ENST00000553591;ENST00000554065	T;D;D;D	0.93426	-1.04;-3.22;-3.22;-3.22	5.85	5.85	0.93711	Purine phosphorylase, family 2, conserved site (1);Nucleoside phosphorylase domain (1);	0.000000	0.85682	D	0.000000	D	0.95101	0.8413	L	0.43646	1.37	0.80722	D	1	P;D	0.89917	0.745;1.0	B;D	0.97110	0.425;1.0	D	0.95493	0.8571	10	0.66056	D	0.02	-16.474	15.2169	0.73274	0.0:0.0:0.0:1.0	.	85;85	Q8N7G1;P00491	.;PNPH_HUMAN	L	85;85;124;6	ENSP00000450663:F85L;ENSP00000354532:F85L;ENSP00000452421:F124L;ENSP00000451108:F6L	ENSP00000354532:F85L	F	+	1	0	PNP	20012542	1.000000	0.71417	1.000000	0.80357	0.731000	0.41821	7.190000	0.77755	2.234000	0.73211	0.533000	0.62120	TTC	PNP-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000073646.2	-49.420863	KEEP		+	6.749168	0.022624	5	216	---	---	---	---	1	0.9971058	2	115	0	100	22	274	0	100	2	0	0	0	0	0	0	22	274	0	100	2	TP
SRCAP	10847	broad.mit.edu	37	16	30732518	30732518	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr16:30732518T>C	ENST00000262518.4	+	21	3647	c.3262T>C	c.(3262-3264)Tcc>Ccc	p.S1088P	SRCAP_ENST00000395059.2_Missense_Mutation_p.S1088P|SRCAP_ENST00000344771.4_Intron	NM_006662.2	NP_006653.2	Q6ZRS2	SRCAP_HUMAN	Snf2-related CREBBP activator protein	1088	Pro-rich.	NA		NA	interspecies interaction between organisms|regulation of transcription from RNA polymerase II promoter|transcription, DNA-dependent	Golgi apparatus|nucleus|protein complex	ATP binding|DNA binding|helicase activity|histone acetyltransferase activity|transcription coactivator activity			NS(1)|breast(3)|cervix(3)|endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(22)|liver(3)|lung(62)|ovary(6)|pancreas(1)|prostate(4)|skin(5)|upper_aerodigestive_tract(3)|urinary_tract(5)	136			Colorectal(24;0.198)			AGTGTTGCCATCCCCCCTGGG	0.592	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													91	99	96	NA		NA	NA	16		NA											NA				30732518		2197	4300	6497	SO:0001583	missense			ENSG00000080603	HGNC:16974	NM_006662	Approved	uc002dze.1	NA	B0JZA6|O15026|Q7Z744|Q9Y5L9	ENST00000262518.4	37	CCDS10689.2	.	.	.	.	.	.	.	.	.	.	T	10.02	1.235528	0.22626	.	.	ENSG00000080603	ENST00000262518;ENST00000395059	D;D	0.91180	-2.8;-2.8	5.36	3.05	0.35203	.	.	.	.	.	T	0.78923	0.4360	N	0.14661	0.345	0.80722	D	1	B;B	0.06786	0.001;0.0	B;B	0.09377	0.004;0.002	T	0.69375	-0.5162	9	0.29301	T	0.29	-6.0325	5.24	0.15467	0.0:0.0979:0.3981:0.504	.	1088;1088	Q6ZRS2-2;Q6ZRS2	.;SRCAP_HUMAN	P	1088	ENSP00000262518:S1088P;ENSP00000378499:S1088P	ENSP00000262518:S1088P	S	+	1	0	SRCAP	30640019	0.983000	0.35010	1.000000	0.80357	0.792000	0.44763	1.117000	0.31234	1.050000	0.40346	0.455000	0.32223	TCC	SRCAP-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000255523.1	-143.876865	KEEP		+	8.053784	0.009158	5	541	---	---	---	---	1	0.1319823	3	51	0	221	7	686	0	221	2	0	0	0	0	0	0	7	686	0	221	2	TP
KARS	3735	broad.mit.edu	37	16	75669879	75669879	+	Silent	SNP	C	C	T	rs143003475		GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr16:75669879C>T	ENST00000319410.5	-	6	805	c.684G>A	c.(682-684)ccG>ccA	p.P228P	KARS_ENST00000568378.1_Intron|KARS_ENST00000302445.3_Silent_p.P200P	NM_001130089.1	NP_001123561.1	Q15046	SYK_HUMAN	lysyl-tRNA synthetase	200		NA		NA	interspecies interaction between organisms|lysyl-tRNA aminoacylation|tRNA processing	cytosol|extracellular region|mitochondrial matrix|nucleus|plasma membrane|soluble fraction	ATP binding|lysine-tRNA ligase activity|metal ion binding|tRNA binding			kidney(1)|large_intestine(3)|lung(8)|ovary(2)|prostate(3)|upper_aerodigestive_tract(1)	18					L-Lysine(DB00123)	TGATCTCATACGGAATGATGC	0.448	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0								C	,	1,4395	2.1+/-5.4	0,1,2197	120	91	101	NA	684,600	3.1	0.5	16	dbSNP_134	101	1,8599	1.2+/-3.3	0,1,4299	no	coding-synonymous,coding-synonymous	KARS	NM_001130089.1,NM_005548.2	,	0,2,6496	TT,TC,CC	NA	0.0116,0.0227,0.0154	,	228/626,200/598	75669879	2,12994	2198	4300	6498	SO:0001819	synonymous_variant			ENSG00000065427	HGNC:6215	NM_005548	Approved	uc002fer.3	NA	A8MSK1|D3DUK4|O14946|Q96J25|Q9HB23	ENST00000319410.5	37	CCDS45532.1																																																																																			KARS-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000269024.1	11.191736	KEEP		-	18.879394	0.125	7	49	---	---	---	---	1	0.928655	174	236	2	53	8	55	2	53	32	0	0	0	0	0	0	8	55	2	53	2	TP
CYB5D2	124936	broad.mit.edu	37	17	4046938	4046938	+	5'UTR	SNP	A	A	C	rs71905319|rs28372950		GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr17:4046938A>C	ENST00000301391.3	+	0	389				CYB5D2_ENST00000573984.1_5'Flank|ZZEF1_ENST00000381638.2_5'Flank|CYB5D2_ENST00000575251.1_5'UTR|ZZEF1_ENST00000574474.1_5'Flank	NM_144611.3	NP_653212.1	Q8WUJ1	NEUFC_HUMAN	cytochrome b5 domain containing 2	NA		NA		NA	nervous system development	extracellular region	heme binding			breast(1)|large_intestine(3)|liver(2)|ovary(1)	7						CTAGCGCGCGAGAGAGAGAGC	0.602	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001623	5_prime_UTR_variant				HGNC:28471	NM_144611	Approved	uc002fxm.4	NA	B2R7R6|D3DTJ9	ENST00000301391.3	37	CCDS11044.1																																																																																			CYB5D2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000438698.1	9.113608	KEEP		+	16.687965	0.115385	6	46	---	---	---	---	1	0.9601808	11	14	0	74	7	51	0	74	2	0	0	0	0	0	0	7	51	0	74	2	TP
TP53	7157	broad.mit.edu	37	17	7577568	7577568	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr17:7577568C>T	ENST00000420246.2	-	7	845	c.713G>A	c.(712-714)tGt>tAt	p.C238Y	TP53_ENST00000269305.4_Missense_Mutation_p.C238Y|TP53_ENST00000413465.2_Missense_Mutation_p.C238Y|TP53_ENST00000445888.2_Missense_Mutation_p.C238Y|TP53_ENST00000574684.1_5'Flank|TP53_ENST00000455263.2_Missense_Mutation_p.C238Y|TP53_ENST00000359597.4_Missense_Mutation_p.C238Y	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	238	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).	NA	C -> F (in sporadic cancers; somatic mutation).|C -> G (in LFS; germline mutation and in sporadic cancers; somatic mutation).|C -> H (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions).|C -> R (in sporadic cancers; somatic mutation).|C -> S (in LFS; germline mutation and in sporadic cancers; somatic mutation).|C -> W (in sporadic cancers; somatic mutation).|C -> Y (in a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation).	NA	activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.C238Y(65)|p.C238F(46)|p.C238S(9)|p.0?(8)|p.?(5)|p.C145F(5)|p.C145Y(5)|p.M237_N239delMCN(4)|p.C238fs*21(1)|p.M237fs*1(1)|p.M144_N146delMCN(1)|p.C238del(1)|p.Y236_M243delYMCNSSCM(1)|p.V225fs*23(1)|p.H233fs*6(1)|p.C238_M246delCNSSCMGGM(1)|p.H233_C242del10(1)|p.N239_C242del(1)|p.C145S(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GGAACTGTTACACATGTAGTT	0.572	NA	111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	158	Substitution - Missense(131)|Deletion - In frame(10)|Whole gene deletion(8)|Unknown(5)|Deletion - Frameshift(4)	breast(22)|ovary(17)|large_intestine(14)|haematopoietic_and_lymphoid_tissue(13)|endometrium(13)|lung(12)|upper_aerodigestive_tract(9)|pancreas(8)|soft_tissue(7)|urinary_tract(7)|oesophagus(7)|biliary_tract(6)|central_nervous_system(6)|liver(5)|bone(5)|stomach(4)|skin(2)|meninges(1)	GRCh37	CM034930	TP53	M							132	103	113	NA		NA	NA	17		NA											NA				7577568		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	C	22.7	4.327056	0.81690	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944	D;D;D;D;D;D;D;D	0.99964	-9.96;-9.96;-9.96;-9.96;-9.96;-9.96;-9.96;-9.96	4.09	4.09	0.47781	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99972	0.9991	M	0.92970	3.365	0.80722	D	1	D;D;D;D;D;D	0.89917	1.0;1.0;1.0;1.0;1.0;1.0	D;D;D;D;D;D	0.97110	1.0;1.0;1.0;1.0;1.0;1.0	D	0.95847	0.8871	10	0.87932	D	0	-18.536	14.6088	0.68501	0.0:1.0:0.0:0.0	.	238;238;145;238;238;238	P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;P53_HUMAN;.;.	Y	238;238;238;238;238;238;227;145;106;145	ENSP00000410739:C238Y;ENSP00000352610:C238Y;ENSP00000269305:C238Y;ENSP00000398846:C238Y;ENSP00000391127:C238Y;ENSP00000391478:C238Y;ENSP00000425104:C106Y;ENSP00000423862:C145Y	ENSP00000269305:C238Y	C	-	2	0	TP53	7518293	1.000000	0.71417	1.000000	0.80357	0.996000	0.88848	7.556000	0.82233	2.564000	0.86499	0.462000	0.41574	TGT	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	347.085487	KEEP		-	375.973785	0.254269	134	393	---	---	---	---	1	1	57	69	0	100	188	532	0	100	2	1	1	257	622	1	1284	188	532	0	100	5	TP
TP53	7157	broad.mit.edu	37	17	7578235	7578235	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr17:7578235T>C	ENST00000420246.2	-	6	746	c.614A>G	c.(613-615)tAt>tGt	p.Y205C	TP53_ENST00000269305.4_Missense_Mutation_p.Y205C|TP53_ENST00000413465.2_Missense_Mutation_p.Y205C|TP53_ENST00000445888.2_Missense_Mutation_p.Y205C|TP53_ENST00000574684.1_Intron|TP53_ENST00000455263.2_Missense_Mutation_p.Y205C|TP53_ENST00000359597.4_Missense_Mutation_p.Y205C	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	205	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.	NA	Y -> C (in sporadic cancers; somatic mutation).|Y -> D (in sporadic cancers; somatic mutation).|Y -> F (in sporadic cancers; somatic mutation).|Y -> H (in sporadic cancers; somatic mutation).|Y -> N (in sporadic cancers; somatic mutation).|Y -> S (in sporadic cancers; somatic mutation).	NA	activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.Y205C(68)|p.Y205S(14)|p.Y205F(8)|p.0?(8)|p.Y112C(5)|p.?(5)|p.Y73C(5)|p.Y73S(1)|p.Y112S(1)|p.E204fs*39(1)|p.E204_N210delEYLDDRN(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GTCATCCAAATACTCCACACG	0.542	NA	111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	117	Substitution - Missense(102)|Whole gene deletion(8)|Unknown(5)|Deletion - In frame(1)|Deletion - Frameshift(1)	lung(20)|upper_aerodigestive_tract(19)|central_nervous_system(10)|large_intestine(9)|biliary_tract(8)|breast(6)|ovary(6)|haematopoietic_and_lymphoid_tissue(5)|endometrium(5)|urinary_tract(5)|bone(5)|soft_tissue(4)|oesophagus(4)|stomach(3)|liver(3)|pancreas(2)|vulva(1)|skin(1)|prostate(1)											136	121	126	NA		NA	NA	17		NA											NA				7578235		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	T	17.85	3.490024	0.64074	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944;ENST00000414315	D;D;D;D;D;D;D;D	0.99872	-7.36;-7.36;-7.36;-7.36;-7.36;-7.36;-7.36;-7.36	5.41	4.33	0.51752	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99840	0.9927	M	0.88906	2.99	0.58432	D	0.999999	D;D;D;D;D;D;D	0.89917	1.0;1.0;1.0;1.0;1.0;1.0;1.0	D;D;D;D;D;D;D	0.91635	0.995;0.998;0.995;0.997;0.999;0.997;0.996	D	0.97320	0.9943	10	0.87932	D	0	-5.8058	9.707	0.40222	0.0:0.0827:0.0:0.9173	.	166;205;205;112;205;205;205	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	C	205;205;205;205;205;205;194;112;73;112;73	ENSP00000410739:Y205C;ENSP00000352610:Y205C;ENSP00000269305:Y205C;ENSP00000398846:Y205C;ENSP00000391127:Y205C;ENSP00000391478:Y205C;ENSP00000425104:Y73C;ENSP00000423862:Y112C	ENSP00000269305:Y205C	Y	-	2	0	TP53	7518960	1.000000	0.71417	0.137000	0.22149	0.045000	0.14185	7.996000	0.88334	1.001000	0.39076	-0.256000	0.11100	TAT	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	177.66776	KEEP		-	179.977725	0.368421	56	96	---	---	---	---	1	1	73	75	0	95	74	124	0	95	2	1	1	148	535	0	1146	74	124	0	95	2	TP
THRA	7067	broad.mit.edu	37	17	38245675	38245675	+	Missense_Mutation	SNP	T	T	G			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr17:38245675T>G	ENST00000450525.2	+	9	1690	c.1199T>G	c.(1198-1200)cTc>cGc	p.L400R	THRA_ENST00000264637.4_Intron|THRA_ENST00000584985.1_Intron|THRA_ENST00000546243.1_Missense_Mutation_p.L400R|THRA_ENST00000394121.4_Intron	NM_199334.3	NP_955366.1	P10827	THA_HUMAN	thyroid hormone receptor, alpha	0		NA		NA	negative regulation of RNA polymerase II transcriptional preinitiation complex assembly|negative regulation of transcription initiation, DNA-dependent|regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor|transcription from RNA polymerase II promoter	cytosol|nucleoplasm	protein domain specific binding|sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity|steroid hormone receptor activity|TBP-class protein binding|thyroid hormone binding|thyroid hormone receptor activity|transcription regulatory region DNA binding|zinc ion binding			endometrium(1)|kidney(3)|large_intestine(2)|lung(4)|prostate(1)	11	Colorectal(19;0.000442)	Myeloproliferative disorder(1115;0.0255)			Levothyroxine(DB00451)|Liothyronine(DB00279)	TTCCCCCCACTCTTCCTCGAG	0.622	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													70	67	68	NA		NA	NA	17		NA											NA				38245675		2203	4300	6503	SO:0001583	missense			ENSG00000126351	HGNC:11796		Approved	uc002htw.3	NA	A8K3B5|P21205|Q8N6A1|Q96H73	ENST00000450525.2	37	CCDS42316.1	.	.	.	.	.	.	.	.	.	.	t	18.74	3.687830	0.68271	.	.	ENSG00000126351	ENST00000450525;ENST00000546243	D;D	0.97430	-4.38;-4.38	4.65	4.65	0.58169	.	.	.	.	.	D	0.95755	0.8619	M	0.77103	2.36	0.46011	D	0.998812	P	0.37141	0.584	B	0.34242	0.178	D	0.95163	0.8283	8	.	.	.	.	13.2169	0.59865	0.0:0.0:0.0:1.0	.	400	Q6FH41	.	R	400	ENSP00000395641:L400R;ENSP00000443972:L400R	.	L	+	2	0	THRA	35499201	1.000000	0.71417	1.000000	0.80357	0.994000	0.84299	7.560000	0.82277	1.948000	0.56530	0.348000	0.21847	CTC	THRA-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000257161.1	54.665042	KEEP		+	55.16294	0.386364	17	27	---	---	---	---	1	1	599	19	0	80	23	31	0	80	2	0	0	0	0	0	0	23	31	0	80	2	TP
LDLR	3949	broad.mit.edu	37	19	11224247	11224247	+	Silent	SNP	T	T	C			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr19:11224247T>C	ENST00000558518.1	+	10	1582	c.1395T>C	c.(1393-1395)taT>taC	p.Y465Y	LDLR_ENST00000557933.1_Silent_p.Y465Y|LDLR_ENST00000535915.1_Silent_p.Y424Y|LDLR_ENST00000455727.2_Silent_p.Y297Y|LDLR_ENST00000545707.1_Silent_p.Y338Y|LDLR_ENST00000558013.1_Silent_p.Y465Y	NM_000527.4|NM_001195798.1	NP_000518.1|NP_001182727.1	P01130	LDLR_HUMAN	low density lipoprotein receptor	465		NA		NA	cholesterol homeostasis|cholesterol metabolic process|interspecies interaction between organisms|intestinal cholesterol absorption|low-density lipoprotein particle clearance|receptor-mediated endocytosis	clathrin-coated endocytic vesicle membrane|coated pit|early endosome|endosome membrane|external side of plasma membrane|integral to plasma membrane|low-density lipoprotein particle|lysosome	calcium ion binding|low-density lipoprotein receptor activity|protein binding|very-low-density lipoprotein particle receptor activity	p.?(1)		breast(2)|endometrium(2)|large_intestine(5)|lung(8)|ovary(2)|pancreas(1)|prostate(1)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(1)	26		Lung NSC(9;0.000245)|Renal(1328;0.0007)|Hepatocellular(1079;0.0524)		GBM - Glioblastoma multiforme(1328;1.36e-05)|STAD - Stomach adenocarcinoma(1328;0.000766)|Lung(535;0.197)	Methyl aminolevulinate(DB00992)|Porfimer(DB00707)	TCTCTTCCTATGACACCGTCA	0.622	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		GBM(18;201 575 7820 21545)					NA		NA		NA		1	Unknown(1)	lung(1)											45	43	44	NA		NA	NA	19		NA											NA				11224247		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000130164	HGNC:6547		Approved	uc002mqk.4	NA	C0JYY8|Q53ZD9|Q9UDH7	ENST00000558518.1	37	CCDS12254.1																																																																																			LDLR-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000415973.2	41.566052	KEEP		+	42.176941	0.361111	13	23	---	---	---	---	1	0.9974966	11	13	0	88	17	33	0	88	2	0	0	0	0	0	0	17	33	0	88	2	TP
PRPF31	26121	broad.mit.edu	37	19	54621969	54621969	+	Missense_Mutation	SNP	T	T	C	rs145505952	byFrequency	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr19:54621969T>C	ENST00000321030.4	+	3	543	c.194T>C	c.(193-195)aTg>aCg	p.M65T	TFPT_ENST00000391759.1_5'Flank|PRPF31_ENST00000419967.1_Missense_Mutation_p.M65T|AC012314.8_ENST00000452097.1_RNA|PRPF31_ENST00000391755.1_Missense_Mutation_p.M65T	NM_015629.3	NP_056444.3	Q8WWY3	PRP31_HUMAN	pre-mRNA processing factor 31	65		NA		NA	assembly of spliceosomal tri-snRNP	Cajal body|MLL1 complex|nuclear speck|U4 snRNP|U4/U6 x U5 tri-snRNP complex|U4atac snRNP	RNA binding|snRNP binding			breast(1)|kidney(1)|large_intestine(2)|lung(3)|ovary(2)|urinary_tract(3)	12	all_cancers(19;0.00681)|all_epithelial(19;0.00362)|all_lung(19;0.0175)|Lung NSC(19;0.0325)|Ovarian(34;0.19)					GAGATTATGATGAAGATTGAG	0.502	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													165	161	162	NA		NA	NA	19		NA											NA				54621969		2203	4300	6503	SO:0001583	missense			ENSG00000105618	HGNC:15446		Approved	uc002qdh.2	NA	Q17RB4|Q8N7F9|Q9H271|Q9Y439	ENST00000321030.4	37	CCDS12879.1	.	.	.	.	.	.	.	.	.	.	T	7.523	0.657061	0.14580	.	.	ENSG00000105618	ENST00000321030;ENST00000445811;ENST00000263436;ENST00000419967;ENST00000445124;ENST00000447810;ENST00000391755	T;D;T;D;D;D	0.89485	-0.94;-2.52;-0.94;-2.52;-2.52;-2.52	4.96	4.96	0.65561	.	0.332611	0.32769	N	0.005672	T	0.70334	0.3212	N	0.01168	-0.975	0.31846	N	0.6228	B;B	0.09022	0.002;0.0	B;B	0.01281	0.0;0.0	T	0.65990	-0.6034	10	0.12103	T	0.63	-22.1877	13.9511	0.64118	0.0:0.0:0.0:1.0	.	65;65	E7ESA8;Q8WWY3	.;PRP31_HUMAN	T	65	ENSP00000324122:M65T;ENSP00000395894:M65T;ENSP00000405166:M65T;ENSP00000408980:M65T;ENSP00000395089:M65T;ENSP00000375635:M65T	ENSP00000263436:M65T	M	+	2	0	PRPF31	59313781	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	2.481000	0.45215	1.997000	0.58415	0.533000	0.62120	ATG	PRPF31-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000141417.2	71.310629	KEEP		+	83.695463	0.206452	32	123	---	---	---	---	1	1	129	197	1	299	36	157	1	299	6	0	0	0	0	0	0	36	157	1	299	2	TP
MGME1	92667	broad.mit.edu	37	20	17950509	17950509	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr20:17950509A>G	ENST00000377710.5	+	2	295	c.7A>G	c.(7-9)Atg>Gtg	p.M3V	SNX5_ENST00000481323.1_5'Flank|SNX5_ENST00000606557.1_5'Flank|SNX5_ENST00000606602.1_5'Flank|SNX5_ENST00000486039.1_5'Flank|SNX5_ENST00000377759.4_5'Flank|MGME1_ENST00000377704.4_Missense_Mutation_p.M3V|MGME1_ENST00000377709.1_Missense_Mutation_p.M3V|SNX5_ENST00000377768.3_5'Flank	NM_052865.2	NP_443097.1			mitochondrial genome maintenance exonuclease 1	NA		NA		NA							NA						CTGAATGAAGATGAAGTTATT	0.408	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													52	52	52	NA		NA	NA	20		NA											NA				17950509		2203	4298	6501	SO:0001583	missense			ENSG00000125871	HGNC:16205	NM_052865	Approved		NA		ENST00000377710.5	37	CCDS13131.1	.	.	.	.	.	.	.	.	.	.	A	17.54	3.415742	0.62511	.	.	ENSG00000125871	ENST00000377710;ENST00000377709;ENST00000377704	T;T;T	0.53206	0.86;0.63;0.63	5.67	5.67	0.87782	.	0.206689	0.64402	D	0.000014	T	0.65228	0.2671	M	0.68952	2.095	0.40816	D	0.98346	D	0.63880	0.993	D	0.68192	0.956	T	0.67377	-0.5686	10	0.48119	T	0.1	-30.2637	13.8729	0.63631	1.0:0.0:0.0:0.0	.	3	Q9BQP7	CT072_HUMAN	V	3	ENSP00000366939:M3V;ENSP00000366938:M3V;ENSP00000366933:M3V	ENSP00000366933:M3V	M	+	1	0	C20orf72	17898509	1.000000	0.71417	0.989000	0.46669	0.649000	0.38597	4.307000	0.59123	2.155000	0.67459	0.459000	0.35465	ATG	MGME1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000078139.1	21.816719	KEEP		+	22.602005	0.304348	7	16	---	---	---	---	1	0.9993276	23	16	0	109	9	20	0	109	2	0	0	0	0	0	0	9	20	0	109	2	TP
COL6A2	0	broad.mit.edu	37	21	47546138	47546138	+	Silent	SNP	C	C	T			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr21:47546138C>T	ENST00000300527.4	+	26	2513	c.2409C>T	c.(2407-2409)gaC>gaT	p.D803D	COL6A2_ENST00000357838.4_Silent_p.D803D|COL6A2_ENST00000397763.1_Silent_p.D803D|COL6A2_ENST00000310645.5_Silent_p.D803D|COL6A2_ENST00000409416.1_Silent_p.D803D	NM_001849.3	NP_001840.3	P12110	CO6A2_HUMAN	collagen, type VI, alpha 2	803	Nonhelical region.|VWFA 2.	NA		NA	axon guidance|cell-cell adhesion|extracellular matrix organization|protein heterotrimerization	collagen|extracellular space|protein complex	extracellular matrix structural constituent|protein binding, bridging			NS(1)|breast(1)|central_nervous_system(7)|endometrium(7)|kidney(5)|liver(1)|lung(15)|ovary(2)|pancreas(1)|skin(2)|upper_aerodigestive_tract(1)	43	Breast(49;0.245)			Colorectal(79;0.0303)|READ - Rectum adenocarcinoma(84;0.0649)		ACATGGAGGACGTCCTCTGCC	0.647	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													136	136	136	NA		NA	NA	21		NA											NA				47546138		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000142173	HGNC:2212		Approved	uc002zia.1	NA	Q13909|Q13910|Q13911|Q14048|Q14049|Q16259|Q16597|Q6P0Q1|Q9UML3|Q9Y4S8	ENST00000300527.4	37	CCDS13728.1																																																																																			COL6A2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000206971.1	56.815273	KEEP		+	57.642236	0.365385	19	33	---	---	---	---	1	1	18	422	1	293	21	40	1	293	8	0	0	0	0	0	0	21	40	1	293	2	TP
PISD	23761	broad.mit.edu	37	22	32017352	32017352	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chr22:32017352C>T	ENST00000382151.2	-	5	982	c.563G>A	c.(562-564)cGt>cAt	p.R188H	PISD_ENST00000478893.1_5'UTR|PISD_ENST00000397500.1_Missense_Mutation_p.R188H|PISD_ENST00000336566.4_Missense_Mutation_p.R221H|PISD_ENST00000266095.5_Missense_Mutation_p.R188H|PISD_ENST00000439502.2_Missense_Mutation_p.R222H			Q9UG56	PISD_HUMAN	phosphatidylserine decarboxylase	222		NA		NA	phospholipid biosynthetic process	mitochondrion	phosphatidylserine decarboxylase activity			central_nervous_system(3)|endometrium(2)|large_intestine(4)|lung(1)|ovary(1)|prostate(1)	12					Phosphatidylserine(DB00144)	TGTGCACATACGCGGGCCCAG	0.627	NA	NA					NA				OREG0003530	type=REGULATORY REGION|Gene=PISD|Dataset=Stanford ENCODE Dataset|EvidenceSubtype=Transient transfection luciferase assay		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													82	78	80	NA		NA	NA	22		NA											NA				32017352		2203	4300	6503	SO:0001583	missense			ENSG00000241878	HGNC:8999		Approved	uc003alk.2	829	B1AKM7|O43207|O95535|Q6IC28|Q96GQ2|Q9UGA9	ENST00000382151.2	37	CCDS13899.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	15.02|15.02	2.709641|2.709641	0.48517|0.48517	.|.	.|.	ENSG00000241878|ENSG00000241878	ENST00000382151;ENST00000266095;ENST00000397500;ENST00000439502;ENST00000336566;ENST00000451635;ENST00000422020|ENST00000435900	.|.	.|.	.|.	5.47|5.47	5.47|5.47	0.80525|0.80525	.|.	0.106594|.	0.64402|.	D|.	0.000003|.	T|T	0.34745|0.34745	0.0908|0.0908	N|N	0.05031|0.05031	-0.125|-0.125	0.51233|0.51233	D|D	0.99991|0.99991	B;B;B;B|.	0.19817|.	0.034;0.039;0.016;0.003|.	B;B;B;B|.	0.22386|.	0.039;0.038;0.01;0.005|.	T|T	0.24297|0.24297	-1.0164|-1.0164	9|5	0.41790|.	T|.	0.15|.	-28.1847|-28.1847	11.7396|11.7396	0.51786|0.51786	0.0:0.9195:0.0:0.0805|0.0:0.9195:0.0:0.0805	.|.	212;222;188;188|.	B1AJZ0;Q9UG56;B1AKM6;Q9UG56-2|.	.;PISD_HUMAN;.;.|.	H|I	188;188;188;222;221;188;188|213	.|.	ENSP00000266095:R188H|.	R|V	-|-	2|1	0|0	PISD|PISD	30347352|30347352	.|.	.|.	0.108000|0.108000	0.21378|0.21378	0.043000|0.043000	0.13939|0.13939	.|.	.|.	2.575000|2.575000	0.86900|0.86900	0.563000|0.563000	0.77884|0.77884	CGT|GTA	PISD-007	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000127976.2	66.744701	KEEP		-	67.223799	0.4	22	33	---	---	---	---	1	1	38	44	0	170	25	39	0	170	2	0	0	0	0	0	0	25	39	0	170	2	TP
PLCXD1	55344	broad.mit.edu	37	X	215977	215977	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chrX:215977T>C	ENST00000381657.2	+	7	1461	c.947T>C	c.(946-948)cTc>cCc	p.L316P	PLCXD1_ENST00000381663.3_Missense_Mutation_p.L316P|PLCXD1_ENST00000399012.1_Missense_Mutation_p.L316P	NM_018390.3	NP_060860.1	Q9NUJ7	PLCX1_HUMAN	phosphatidylinositol-specific phospholipase C, X domain containing 1	316		NA		NA	intracellular signal transduction|lipid metabolic process		phospholipase C activity			endometrium(3)|large_intestine(1)|lung(7)	11		all_cancers(21;4.28e-07)|all_epithelial(21;2.07e-08)|all_lung(23;2.81e-05)|Lung NSC(23;0.000693)|Lung SC(21;0.122)				GTCATCGCGCTCAATCAGAAG	0.602	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													84	75	78	NA		NA	NA	X		NA											NA				215977		2203	4296	6499	SO:0001583	missense			ENSG00000182378	HGNC:23148	NM_018390	Approved	uc004cpc.3	NA	A2BH51|A2BH52	ENST00000381657.2	37	CCDS14103.1	.	.	.	.	.	.	.	.	.	.	.	11.51	1.658833	0.29515	.	.	ENSG00000182378	ENST00000399012;ENST00000381657;ENST00000381663	.	.	.	1.77	1.77	0.24775	PLC-like phosphodiesterase, TIM beta/alpha-barrel domain (2);	0.000000	0.64402	D	0.000001	T	0.55862	0.1947	.	.	.	0.23972	N	0.996303	D	0.89917	1.0	D	0.91635	0.999	T	0.38520	-0.9657	8	0.44086	T	0.13	-32.3693	8.048	0.30562	0.0:0.0:0.0:1.0	.	316	Q9NUJ7	PLCX1_HUMAN	P	316	.	ENSP00000371073:L316P	L	+	2	0	PLCXD1	155977	1.000000	0.71417	0.661000	0.29709	0.018000	0.09664	4.999000	0.63934	0.762000	0.33152	0.151000	0.16131	CTC	PLCXD1-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000058879.2	27.76729	KEEP		+	28.430862	0.333333	9	18	---	---	---	---	1	0.9992265	17	45	1	138	10	25	1	138	4	0	0	0	0	0	0	10	25	1	138	2	TP
BHLHB9	80823	broad.mit.edu	37	X	102003861	102003861	+	5'UTR	SNP	G	G	A			GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2625-Tumor-SM-17P3D	GBM-TCGA-19-2625-Normal-SM-1QXXE	g.chrX:102003861G>A	ENST00000372735.1	+	0	523				BHLHB9_ENST00000448867.1_5'UTR|BHLHB9_ENST00000447531.1_5'UTR|BHLHB9_ENST00000457056.1_5'UTR|BHLHB9_ENST00000361229.4_5'UTR			Q6PI77	BHLH9_HUMAN	basic helix-loop-helix domain containing, class B, 9	NA		NA		NA		cytoplasm|nucleus	binding			cervix(1)|endometrium(6)|kidney(3)|large_intestine(1)|lung(8)|ovary(3)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	26						TTAAGACTTCGACCTAGGACA	0.463	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001623	5_prime_UTR_variant			ENSG00000198908	HGNC:29353	NM_030639	Approved	uc011mrv.2	NA	Q9C0G2	ENST00000372735.1	37	CCDS14502.1																																																																																			BHLHB9-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000057630.1	92.767804	KEEP		+	93.439415	0.39726	29	44	---	---	---	---	1	0.8590821	7	0	0	37	37	51	0	37	2	0	0	0	0	0	0	37	51	0	37	2	TP
